Jorma Sormunen

5PUBLICATIONS
33CO-AUTHORS
Exercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursLabour, migration and development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 07, 2025
Is Exercise During Androgen Deprivation Therapy Effective and Safe? A Randomized Controlled Trial.

Lauri Rantaniemi, Ilkka Jussila, Aino Siltari

|Feb 05, 2025
The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial.

Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää

|Jan 27, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial.

Santeri A Pakola, James H A Clubb, Tatiana V Kudling

|Mar 28, 2024
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial.

Santeri A Pakola, Katriina J Peltola, James H A Clubb

|Oct 29, 2017
Cohort profile: a nationwide cohort of Finnish military recruits born in 1958 to study the impact of lifestyle factors in early adulthood on disease outcomes.

Jorma Sormunen, Melina Arnold, Isabelle Soerjomataram

Pageof 1

Frequent Collaborators

3 joint publications

Santeri Pakola

3 joint publications

Elise Jirovec

3 joint publications

Tuomo Alanko

3 joint publications

Akseli Hemminki